Madeleine R. Heldman, MD, MS, discusses managing cytomegalovirus, including advances in CMV assessment and antiviral and immune strategies.

The mortality rate from CMV infection is as high as 90% if it is left untreated. CMV disease usually manifests 1-4 months after transplantation or after completion of antiviral prophylactic drug ...

The infection can cause temporary and permanent disabilities including: About 33% of pregnant women infected with CMV pass the disease on to their unborn child. Symptoms may be present at ...

The National Congenital CMV Disease Registry provides useful information on Cytomegalovirus Disease. Read through our list of frequently asked questions and answers below. Find the answers to your ...

every 12 hSevere CMV disease, GI disease, pneumonia, CNS disease: Ganciclovir 5 mg/kg iv. every 12 hGanciclovir-resistant CMV disease: Foscarnet 60 mg/kg iv. every 8 h or 90 mg/kg iv. every 12 h ...

Congenital cytomegalovirus (CMV) infection is a leading cause of sensorineural hearing loss (SNHL) in children. Whether connexin mutations are factors in the development of CMV-related hearing ...

A new study found a link between human cytomegalovirus (HCMV), a common type of herpes virus, and Alzheimer’s disease. The findings suggest that HCMV can infect the gut and travel to the brain ...

While antiretroviral therapy (ART) can suppress HIV replication indefinitely, people living with HIV are still prone to chronic inflammation that can contribute to co-morbidities such as ...

BioViva’s early-stage CMV projects are looking at metabolic disease, frailty, cardiovascular disease, chronic kidney disease (CKD), and chronic obstructive pulmonary disease (COPD).